ADHD2
MCID: ATT020
MIFTS: 15

Attention Deficit-Hyperactivity Disorder 2 (ADHD2)

Categories: Genetic diseases, Mental diseases, Neuronal diseases

Aliases & Classifications for Attention Deficit-Hyperactivity Disorder 2

MalaCards integrated aliases for Attention Deficit-Hyperactivity Disorder 2:

Name: Attention Deficit-Hyperactivity Disorder 2 58
Attention Deficit-Hyperactivity Disorder, Susceptibility to, 2 58 13
Adhd2 58

Classifications:



External Ids:

OMIM 58 608904

Summaries for Attention Deficit-Hyperactivity Disorder 2

MalaCards based summary : Attention Deficit-Hyperactivity Disorder 2, also known as attention deficit-hyperactivity disorder, susceptibility to, 2, is related to attention deficit-hyperactivity disorder and anxiety. An important gene associated with Attention Deficit-Hyperactivity Disorder 2 is ADHD2 (Attention Deficit-Hyperactivity Disorder, Susceptibility To, 2). The drugs Ethanol and Anti-Infective Agents, Local have been mentioned in the context of this disorder.

Description from OMIM: 608904

Related Diseases for Attention Deficit-Hyperactivity Disorder 2

Diseases in the Attention Deficit-Hyperactivity Disorder family:

Attention Deficit-Hyperactivity Disorder 1 Attention Deficit-Hyperactivity Disorder 2
Attention Deficit-Hyperactivity Disorder 3 Attention Deficit-Hyperactivity Disorder 4

Diseases related to Attention Deficit-Hyperactivity Disorder 2 via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 attention deficit-hyperactivity disorder 29.7 ADHD2 SLC6A3
2 anxiety 10.1
3 pol iii-related leukodystrophies 10.1

Symptoms & Phenotypes for Attention Deficit-Hyperactivity Disorder 2

Clinical features from OMIM:

608904

Drugs & Therapeutics for Attention Deficit-Hyperactivity Disorder 2

Drugs for Attention Deficit-Hyperactivity Disorder 2 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):


# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethanol Approved 64-17-5 702
2 Anti-Infective Agents, Local
3 Central Nervous System Depressants
4 Anti-Infective Agents
5 Detox adjuvant

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Software Treatment for Actively Reducing Severity of ADHD - Follow Up Completed NCT02828644 Not Applicable
2 Identification of Biomarkers of Attention Deficit Disorder With or Without Hyperactivity (ADHD) by a Metabolomic Approach in Children Recruiting NCT03436017
3 ADHD: Gaps Between Patients With Alcohol-dependence and Impact on Relapse Recruiting NCT02364817

Search NIH Clinical Center for Attention Deficit-Hyperactivity Disorder 2

Genetic Tests for Attention Deficit-Hyperactivity Disorder 2

Anatomical Context for Attention Deficit-Hyperactivity Disorder 2

Publications for Attention Deficit-Hyperactivity Disorder 2

Articles related to Attention Deficit-Hyperactivity Disorder 2:

# Title Authors Year
1
Extended-release Methylphenidate Treatment and Outcomes in Comorbid Social Anxiety Disorder and Attention-deficit/Hyperactivity Disorder: 2 Case Reports. ( 25955266 )
2015

Variations for Attention Deficit-Hyperactivity Disorder 2

Expression for Attention Deficit-Hyperactivity Disorder 2

Search GEO for disease gene expression data for Attention Deficit-Hyperactivity Disorder 2.

Pathways for Attention Deficit-Hyperactivity Disorder 2

GO Terms for Attention Deficit-Hyperactivity Disorder 2

Sources for Attention Deficit-Hyperactivity Disorder 2

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....